Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Equity Ratio (2016 - 2026)

Integra Lifesciences Holdings' Equity Ratio history spans 17 years, with the latest figure at 0.29 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 24.31% to 0.29 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.29, a 24.31% decrease, with the full-year FY2025 number at 0.29, down 24.31% from a year prior.
  • Equity Ratio hit 0.29 in Q4 2025 for Integra Lifesciences Holdings, up from 0.28 in the prior quarter.
  • Over the last five years, Equity Ratio for IART hit a ceiling of 0.46 in Q4 2022 and a floor of 0.28 in Q2 2025.
  • Historically, Equity Ratio has averaged 0.4 across 5 years, with a median of 0.42 in 2023.
  • Biggest five-year swings in Equity Ratio: rose 7.62% in 2022 and later fell 24.79% in 2025.
  • Tracing IART's Equity Ratio over 5 years: stood at 0.45 in 2021, then grew by 4.14% to 0.46 in 2022, then fell by 9.49% to 0.42 in 2023, then decreased by 8.84% to 0.38 in 2024, then dropped by 24.31% to 0.29 in 2025.
  • Business Quant data shows Equity Ratio for IART at 0.29 in Q4 2025, 0.28 in Q3 2025, and 0.28 in Q2 2025.